Bottom line
SUHAX vs RYHIX: the short answer
SUHAX (DWS Health and Wellness Fund) and RYHIX (Health Care Fund) are both mutual funds.
But RYHIX is far broader, holding 135 positions to 65 for SUHAX, so beyond the top names it adds exposure SUHAX doesn't have.
SUHAX is cheaper at 1.34% vs 1.38% — a difference of $4.00 a year per $10,000 invested.
SUHAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
SUHAX vs RYHIX side by side
| SUHAX | RYHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | DWS (Xtrackers) | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.34% | 1.38% |
| Annual cost per $10k | $134 | $138 |
| 10-yr cost on $10k (prospectus) | $2,095 | $1,709 |
| Max front load | 5.75% | — |
| 12b-1 fee | 0.24% | 0% |
| 1-yr return | — | +14.4% |
| 5-yr return (annualized) | — | +5.1% |
| 10-yr return (annualized) | — | +7.9% |
| Best quarter | +17.1% | +18.7% |
| Worst quarter | −12.1% | −14.4% |
| Net assets (fund) | $231.8M | $19.4M |
| Number of holdings | 65 | 135 |
| Portfolio turnover | 2% | 244% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SUHAX | RYHIX | Difference |
|---|---|---|---|
| 2025 | +12.3% | +14.4% | −2.2% |
| 2024 | +3.3% | +0.6% | +2.7% |
| 2023 | +5.1% | +5.8% | −0.7% |
| 2022 | −7.4% | −11.6% | +4.2% |
| 2021 | +15.0% | +19.2% | −4.2% |
| 2020 | +15.1% | +18.9% | −3.8% |
| 2019 | +21.9% | +22.8% | −0.8% |
| 2018 | +3.3% | +1.6% | +1.7% |
| 2017 | +19.0% | +23.5% | −4.5% |
| 2016 | −10.5% | −9.4% | −1.1% |
Source: Fund prospectus bar charts
Holdings overlap
20 of SUHAX's top 25 holdings also appear in RYHIX's top 25.
| Holding | SUHAX | RYHIX |
|---|---|---|
| Eli Lilly & Co | 13.85% | 3.63% |
| Johnson & Johnson | 6.19% | 2.88% |
| UnitedHealth Group Inc | 5.73% | 2.22% |
| AbbVie Inc | 4.90% | 2.52% |
| Merck & Co Inc | 4.85% | 2.04% |
| Thermo Fisher Scientific Inc | 3.46% | 1.61% |
| Amgen Inc | 2.88% | 1.56% |
| Gilead Sciences Inc | 2.78% | 1.39% |
| Intuitive Surgical Inc | 2.69% | 1.31% |
| Stryker Corp | 2.61% | 1.21% |
| Vertex Pharmaceuticals Inc | 2.45% | 1.34% |
| Abbott Laboratories | 2.39% | 1.42% |
| Danaher Corp | 2.13% | 1.30% |
| Boston Scientific Corp | 2.10% | 0.86% |
| McKesson Corp | 2.05% | 1.05% |
Source: SEC Form N-PORT
SUHAX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between SUHAX and RYHIX?
Which is cheaper, SUHAX or RYHIX?
Should I own both SUHAX and RYHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.